Summary
Jelena Aleksic is a geneticist-turned-entrepreneur with 13 years of experience building and commercialising life-science and algorithmic products from bench to market. She co-founded and served as CBO of VC-backed PharmEnable Therapeutics, reimagining small-molecule discovery with AI, and previously founded GeneAdviser, an NHS-adopted genomic testing marketplace. Today she advises Protalea Bio on preventative therapeutics, directs commercial strategy for Signalsmith Audio’s DSP algorithms, and mentors biotech startups and female founders across Cambridge accelerators. Her background blends deep genomics and bioinformatics (PhD, Cambridge) with hands-on startup scaling and partnership wins, including industry awards for deep tech collaboration and entrepreneurship. Beyond business, she has a long track record in scientific capacity building through TReND in Africa and CamRARE, reflecting a commitment to equitable research ecosystems. Colleagues describe her as a strategic connector who translates complex biology into investable products and clear commercial pathways.
13 years of coding experience
12 years of employment as a software developer
Bachelor of Science (BSc) Genetics, Bachelor of Science (BSc) Genetics at The University of Edinburgh
Doctor of Philosophy (PhD) Genome Sciences/Genomics, Doctor of Philosophy (PhD) Genome Sciences/Genomics at University of Cambridge
English, Serbian, Spanish